APO Research
Talk to an analyst

APO RESEARCH · REPORT

Female Oral Contraceptives

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Female Oral Contraceptives Industry Growth and Trends Forecast to 2032

22 December 2025103 pages

Choose your research edition.

Industry ResearchFemale Oral Contraceptives Industry Research Report 2026128 pages · $2,950 USDIndustry Growth & TrendsGlobal Female Oral Contraceptives Industry Growth and Trends Forecast to 2032103 pages · $3,450 USDMarket StructureGlobal Female Oral Contraceptives Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032194 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Female Oral Contraceptives Market Outlook and Growth Opportunities 2026191 pages · $4,250 USDMarket Analysis & ForecastGlobal Female Oral Contraceptives Market Analysis and Forecast 2026-2032199 pages · $4,950 USD

Market perspective

The global Female Oral Contraceptives market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Female Oral Contraceptives is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Female Oral Contraceptives is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Female Oral Contraceptives is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Female Oral Contraceptives include Allergan,plc (Actavis), Mankind Pharma, Piramal Enterprises, Syzygy Healthcare, Bayer, Ferring B.V, Pfizer, Merck and Teva Pharmaceutical, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Female Oral Contraceptives market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Female Oral Contraceptives market size, estimates, and forecasts are presented in terms of sales volume (k units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Female Oral Contraceptives market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Female Oral Contraceptives.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Female Oral Contraceptives market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Female Oral Contraceptives Market by Company

Allergan,plc (Actavis)

Mankind Pharma

Piramal Enterprises

Syzygy Healthcare

Bayer

Ferring B.V

Pfizer

Merck

Teva Pharmaceutical

Janssen Global Services

Female Oral Contraceptives Segment by Type

Continuous Use Pill

Combination Pill

Progestin-only Pill

Female Oral Contraceptives Segment by Application

Online Sales

Offline Sales

Female Oral Contraceptives Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Female Oral Contraceptives market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Female Oral Contraceptives and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Female Oral Contraceptives.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Female Oral Contraceptives manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Female Oral Contraceptives in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Continuous Use Pill Table 2. Major Company of Combination Pill Table 3. Major Company of Progestin-only Pill Table 4. Global Female Oral Contraceptives Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Female Oral Contraceptives Sales by Type (2021-2026) & (k units) Table 6. Global Female Oral Contraceptives Sales Market Share in Volume by Type (2021-2026) Table 7. Global Female Oral Contraceptives Sales by Type (2021-2026) & (US$ Million) Table 8. Global Female Oral Contraceptives Sales Market Share in Value by Type (2021-2026) Table 9. Global Female Oral Contraceptives Price by Type (2021-2026) & (US$/unit) Table 10. Global Female Oral Contraceptives Sales by Type (2027-2032) & (k units) Table 11. Global Female Oral Contraceptives Sales Market Share in Volume by Type (2027-2032) Table 12. Global Female Oral Contraceptives Sales by Type (2027-2032) & (US$ Million) Table 13. Global Female Oral Contraceptives Sales Market Share in Value by Type (2027-2032) Table 14. Global Female Oral Contraceptives Price by Type (2027-2032) & (US$/unit) Table 15. North America Female Oral Contraceptives Sales by Type (2021-2026) & (k units) Table 16. North America Female Oral Contraceptives Sales by Type (2021-2026) & (US$ Million) Table 17. Europe Female Oral Contraceptives Sales by Type (2021-2026) & (k units) Table 18. Europe Female Oral Contraceptives Sales by Type (2021-2026) & (US$ Million) Table 19. Asia-Pacific Female Oral Contraceptives Sales by Type (2021-2026) & (k units) Table 20. Asia-Pacific Female Oral Contraceptives Sales by Type (2021-2026) & (US$ Million) Table 21. Latin America Female Oral Contraceptives Sales by Type (2021-2026) & (k units) Table 22. Latin America Female Oral Contraceptives Sales by Type (2021-2026) & (US$ Million) Table 23. Middle East and Africa Female Oral Contraceptives Sales by Type (2021-2026) & (k units) Table 24. Middle East and Africa Female Oral Contraceptives Sales by Type (2021-2026) & (US$ Million) Table 25. Female Oral Contraceptives Industry Trends Table 26. Female Oral Contraceptives Industry Drivers Table 27. Female Oral Contraceptives Industry Opportunities and Challenges Table 28. Female Oral Contraceptives Industry Restraints Table 29. Global Female Oral Contraceptives Sales Revenue by Company (US$ Million) & (2021-2026) Table 30. Global Female Oral Contraceptives Revenue Market Share by Company (2021-2026) Table 31. Global Female Oral Contraceptives Sales by Company (2021-2026) & (k units) Table 32. Global Female Oral Contraceptives Sales Share by Company (2021-2026) Table 33. Global Female Oral Contraceptives Market Price by Company (2021-2026) & (US$/unit) Table 34. Global Female Oral Contraceptives Industry Company Ranking, 2024 VS 2025 VS 2026 Table 35. Global Female Oral Contraceptives Major Company Production Sites and Headquarters Table 36. Global Female Oral Contraceptives Company, Product Type & Application Table 37. Global Female Oral Contraceptives Company Establishment Date Table 38. Global Company Market Concentration Ratio (CR5 and HHI) Table 39. Global Female Oral Contraceptives by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 40. Global Female Oral Contraceptives Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 41. Global Female Oral Contraceptives Sales by Region (2021-2026) & (k units) Table 42. Global Female Oral Contraceptives Sales Market Share in Volume by Region (2021-2026) Table 43. Global Female Oral Contraceptives Sales by Region (2021-2026) & (US$ Million) Table 44. Global Female Oral Contraceptives Sales Market Share in Value by Region (2021-2026) Table 45. Global Female Oral Contraceptives Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 46. Global Female Oral Contraceptives Sales by Region (2027-2032) & (k units) Table 47. Global Female Oral Contraceptives Sales Market Share in Volume by Region (2027-2032) Table 48. Global Female Oral Contraceptives Sales by Region (2027-2032) & (US$ Million) Table 49. Global Female Oral Contraceptives Sales Market Share in Value by Region (2027-2032) Table 50. Global Female Oral Contraceptives Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2027-2032) Table 51. Global Female Oral Contraceptives Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 52. Global Female Oral Contraceptives Sales by Application (2021-2026) & (k units) Table 53. Global Female Oral Contraceptives Sales Market Share in Volume by Application (2021-2026) Table 54. Global Female Oral Contraceptives Sales by Application (2021-2026) & (US$ Million) Table 55. Global Female Oral Contraceptives Sales Market Share in Value by Application (2021-2026) Table 56. Global Female Oral Contraceptives Price by Application (2021-2026) & (US$/unit) Table 57. Global Female Oral Contraceptives Sales by Application (2027-2032) & (k units) Table 58. Global Female Oral Contraceptives Sales Market Share in Volume by Application (2027-2032) Table 59. Global Female Oral Contraceptives Sales by Application (2027-2032) & (US$ Million) Table 60. Global Female Oral Contraceptives Sales Market Share in Value by Application (2027-2032) Table 61. Global Female Oral Contraceptives Price by Application (2027-2032) & (US$/unit) Table 62. North America Female Oral Contraceptives Sales by Application (2021-2026) & (k units) Table 63. North America Female Oral Contraceptives Sales by Application (2021-2026) & (US$ Million) Table 64. Europe Female Oral Contraceptives Sales by Application (2021-2026) & (k units) Table 65. Europe Female Oral Contraceptives Sales by Application (2021-2026) & (US$ Million) Table 66. Asia-Pacific Female Oral Contraceptives Sales by Application (2021-2026) & (k units) Table 67. Asia-Pacific Female Oral Contraceptives Sales by Application (2021-2026) & (US$ Million) Table 68. Latin America Female Oral Contraceptives Sales by Application (2021-2026) & (k units) Table 69. Latin America Female Oral Contraceptives Sales by Application (2021-2026) & (US$ Million) Table 70. Middle East and Africa Female Oral Contraceptives Sales by Application (2021-2026) & (k units) Table 71. Middle East and Africa Female Oral Contraceptives Sales by Application (2021-2026) & (US$ Million) Table 72. Allergan,plc (Actavis) Company Information Table 73. Allergan,plc (Actavis) Business Overview Table 74. Allergan,plc (Actavis) Female Oral Contraceptives Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 75. Allergan,plc (Actavis) Female Oral Contraceptives Product Portfolio Table 76. Allergan,plc (Actavis) Recent Development Table 77. Mankind Pharma Company Information Table 78. Mankind Pharma Business Overview Table 79. Mankind Pharma Female Oral Contraceptives Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 80. Mankind Pharma Female Oral Contraceptives Product Portfolio Table 81. Mankind Pharma Recent Development Table 82. Piramal Enterprises Company Information Table 83. Piramal Enterprises Business Overview Table 84. Piramal Enterprises Female Oral Contraceptives Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 85. Piramal Enterprises Female Oral Contraceptives Product Portfolio Table 86. Piramal Enterprises Recent Development Table 87. Syzygy Healthcare Company Information Table 88. Syzygy Healthcare Business Overview Table 89. Syzygy Healthcare Female Oral Contraceptives Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 90. Syzygy Healthcare Female Oral Contraceptives Product Portfolio Table 91. Syzygy Healthcare Recent Development Table 92. Bayer Company Information Table 93. Bayer Business Overview Table 94. Bayer Female Oral Contraceptives Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 95. Bayer Female Oral Contraceptives Product Portfolio Table 96. Bayer Recent Development Table 97. Ferring B.V Company Information Table 98. Ferring B.V Business Overview Table 99. Ferring B.V Female Oral Contraceptives Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 100. Ferring B.V Female Oral Contraceptives Product Portfolio Table 101. Ferring B.V Recent Development Table 102. Pfizer Company Information Table 103. Pfizer Business Overview Table 104. Pfizer Female Oral Contraceptives Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 105. Pfizer Female Oral Contraceptives Product Portfolio Table 106. Pfizer Recent Development Table 107. Merck Company Information Table 108. Merck Business Overview Table 109. Merck Female Oral Contraceptives Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 110. Merck Female Oral Contraceptives Product Portfolio Table 111. Merck Recent Development Table 112. Teva Pharmaceutical Company Information Table 113. Teva Pharmaceutical Business Overview Table 114. Teva Pharmaceutical Female Oral Contraceptives Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 115. Teva Pharmaceutical Female Oral Contraceptives Product Portfolio Table 116. Teva Pharmaceutical Recent Development Table 117. Janssen Global Services Company Information Table 118. Janssen Global Services Business Overview Table 119. Janssen Global Services Female Oral Contraceptives Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 120. Janssen Global Services Female Oral Contraceptives Product Portfolio Table 121. Janssen Global Services Recent Development Table 122. North America Female Oral Contraceptives Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 123. North America Female Oral Contraceptives Sales by Country (2021-2026) & (k units) Table 124. North America Female Oral Contraceptives Sales Market Share by Country (2021-2026) Table 125. North America Female Oral Contraceptives Sales Forecast by Country (2027-2032) & (k units) Table 126. North America Female Oral Contraceptives Sales Market Share Forecast by Country (2027-2032) Table 127. North America Female Oral Contraceptives Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 128. North America Female Oral Contraceptives Market Size by Country (2021-2026) & (US$ Million) Table 129. North America Female Oral Contraceptives Market Share by Country (2021-2026) Table 130. North America Female Oral Contraceptives Market Size Forecast by Country (2027-2032) & (US$ Million) Table 131. North America Female Oral Contraceptives Market Share Forecast by Country (2027-2032) Table 132. Europe Female Oral Contraceptives Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 133. Europe Female Oral Contraceptives Sales by Country (2021-2026) & (k units) Table 134. Europe Female Oral Contraceptives Sales Market Share by Country (2021-2026) Table 135. Europe Female Oral Contraceptives Sales Forecast by Country (2027-2032) & (k units) Table 136. Europe Female Oral Contraceptives Sales Market Share Forecast by Country (2027-2032) Table 137. Europe Female Oral Contraceptives Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 138. Europe Female Oral Contraceptives Market Size by Country (2021-2026) & (US$ Million) Table 139. Europe Female Oral Contraceptives Market Share by Country (2021-2026) Table 140. Europe Female Oral Contraceptives Market Size Forecast by Country (2027-2032) & (US$ Million) Table 141. Europe Female Oral Contraceptives Market Share Forecast by Country (2027-2032) Table 142. Asia-Pacific Female Oral Contraceptives Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 143. Asia-Pacific Female Oral Contraceptives Sales by Country (2021-2026) & (k units) Table 144. Asia-Pacific Female Oral Contraceptives Sales Market Share by Country (2021-2026) Table 145. Asia-Pacific Female Oral Contraceptives Sales Forecast by Country (2027-2032) & (k units) Table 146. Asia-Pacific Female Oral Contraceptives Sales Market Share Forecast by Country (2027-2032) Table 147. Asia-Pacific Female Oral Contraceptives Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 148. Asia-Pacific Female Oral Contraceptives Market Size by Country (2021-2026) & (US$ Million) Table 149. Asia-Pacific Female Oral Contraceptives Market Share by Country (2021-2026) Table 150. Asia-Pacific Female Oral Contraceptives Market Size Forecast by Country (2027-2032) & (US$ Million) Table 151. Asia-Pacific Female Oral Contraceptives Market Share Forecast by Country (2027-2032) Table 152. Latin America Female Oral Contraceptives Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 153. Latin America Female Oral Contraceptives Sales by Country (2021-2026) & (k units) Table 154. Latin America Female Oral Contraceptives Sales Market Share by Country (2021-2026) Table 155. Latin America Female Oral Contraceptives Sales Forecast by Country (2027-2032) & (k units) Table 156. Latin America Female Oral Contraceptives Sales Market Share Forecast by Country (2027-2032) Table 157. Latin America Female Oral Contraceptives Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 158. Latin America Female Oral Contraceptives Market Size by Country (2021-2026) & (US$ Million) Table 159. Latin America Female Oral Contraceptives Market Share by Country (2021-2026) Table 160. Latin America Female Oral Contraceptives Market Size Forecast by Country (2027-2032) & (US$ Million) Table 161. Latin America Female Oral Contraceptives Market Share Forecast by Country (2027-2032) Table 162. Middle East and Africa Female Oral Contraceptives Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 163. Middle East and Africa Female Oral Contraceptives Sales by Country (2021-2026) & (k units) Table 164. Middle East and Africa Female Oral Contraceptives Sales Market Share by Country (2021-2026) Table 165. Middle East and Africa Female Oral Contraceptives Sales Forecast by Country (2027-2032) & (k units) Table 166. Middle East and Africa Female Oral Contraceptives Sales Market Share Forecast by Country (2027-2032) Table 167. Middle East and Africa Female Oral Contraceptives Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 168. Middle East and Africa Female Oral Contraceptives Market Size by Country (2021-2026) & (US$ Million) Table 169. Middle East and Africa Female Oral Contraceptives Market Share by Country (2021-2026) Table 170. Middle East and Africa Female Oral Contraceptives Market Size Forecast by Country (2027-2032) & (US$ Million) Table 171. Middle East and Africa Female Oral Contraceptives Market Share Forecast by Country (2027-2032) Table 172. Key Raw Materials Table 173. Raw Materials Key Suppliers Table 174. Female Oral Contraceptives Distributors List Table 175. Female Oral Contraceptives Customers List Table 176. Research Programs/Design for This Report Table 177. Authors List of This Report Table 178. Secondary Sources Table 179. Primary Sources List of Figures Figure 1. Female Oral Contraceptives Image Figure 2. Global Female Oral Contraceptives Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Female Oral Contraceptives Market Size (2021-2032) & (US$ Million) Figure 4. Global Female Oral Contraceptives Sales (2021-2032) & (k units) Figure 5. Continuous Use Pill Image Figure 6. Global Continuous Use Pill Sales YoY Growth (2021-2032) & (k units) Figure 7. Combination Pill Image Figure 8. Global Combination Pill Sales YoY Growth (2021-2032) & (k units) Figure 9. Progestin-only Pill Image Figure 10. Global Progestin-only Pill Sales YoY Growth (2021-2032) & (k units) Figure 11. Global Female Oral Contraceptives Market Size Overview by Type (2021-2032) & (US$ Million) Figure 12. Global Female Oral Contraceptives Market Share by Type 2025 VS 2032 Figure 13. North America Female Oral Contraceptives Sales Market Share in Volume by Type in 2025 Figure 14. North America Female Oral Contraceptives Sales Market Share in Value by Type in 2025 Figure 15. Europe Female Oral Contraceptives Sales Market Share in Volume by Type in 2025 Figure 16. Europe Female Oral Contraceptives Sales Market Share in Value by Type in 2025 Figure 17. Asia-Pacific Female Oral Contraceptives Sales Market Share in Volume by Type in 2025 Figure 18. Asia-Pacific Female Oral Contraceptives Sales Market Share in Value by Type in 2025 Figure 19. Latin America Female Oral Contraceptives Sales Market Share in Volume by Type in 2025 Figure 20. Latin America Female Oral Contraceptives Sales Market Share in Value by Type in 2025 Figure 21. Middle East and Africa Female Oral Contraceptives Sales Market Share in Volume by Type in 2025 Figure 22. Middle East and Africa Female Oral Contraceptives Sales Market Share in Value by Type in 2025 Figure 23. Global Top 5 and 10 Female Oral Contraceptives Players Market Share by Revenue in 2025 Figure 24. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 25. Online Sales Image Figure 26. Global Online Sales Sales YoY Growth (2021-2032) & (k units) Figure 27. Offline Sales Image Figure 28. Global Offline Sales Sales YoY Growth (2021-2032) & (k units) Figure 29. Global Female Oral Contraceptives Market Size Overview by Application (2021-2032) & (US$ Million) Figure 30. Global Female Oral Contraceptives Market Share by Application 2025 VS 2032 Figure 31. North America Female Oral Contraceptives Sales Market Share in Volume by Application in 2025 Figure 32. North America Female Oral Contraceptives Sales Market Share in Value by Application in 2025 Figure 33. Europe Female Oral Contraceptives Sales Market Share in Volume by Application in 2025 Figure 34. Europe Female Oral Contraceptives Sales Market Share in Value by Application in 2025 Figure 35. Asia-Pacific Female Oral Contraceptives Sales Market Share in Volume by Application in 2025 Figure 36. Asia-Pacific Female Oral Contraceptives Sales Market Share in Value by Application in 2025 Figure 37. Latin America Female Oral Contraceptives Sales Market Share in Volume by Application in 2025 Figure 38. Latin America Female Oral Contraceptives Sales Market Share in Value by Application in 2025 Figure 39. Middle East and Africa Female Oral Contraceptives Sales Market Share in Volume by Application in 2025 Figure 40. Middle East and Africa Female Oral Contraceptives Sales Market Share in Value by Application in 2025 Figure 41. North America Female Oral Contraceptives Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 42. North America Female Oral Contraceptives Sales Share by Country: 2021 VS 2025 VS 2032 Figure 43. North America Female Oral Contraceptives Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 44. North America Female Oral Contraceptives Market Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Female Oral Contraceptives Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 46. Europe Female Oral Contraceptives Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Female Oral Contraceptives Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. Europe Female Oral Contraceptives Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Female Oral Contraceptives Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 50. Asia-Pacific Female Oral Contraceptives Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Female Oral Contraceptives Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Asia-Pacific Female Oral Contraceptives Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Female Oral Contraceptives Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 54. Latin America Female Oral Contraceptives Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Female Oral Contraceptives Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Latin America Female Oral Contraceptives Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Female Oral Contraceptives Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 58. Middle East and Africa Female Oral Contraceptives Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Female Oral Contraceptives Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Middle East and Africa Female Oral Contraceptives Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Female Oral Contraceptives Value Chain Figure 62. Key Raw Materials Price Figure 63. Manufacturing Cost Structure Figure 64. Female Oral Contraceptives Production Mode & Process Figure 65. Direct Comparison with Distribution Share Figure 66. Distributors Profiles Figure 67. Years Considered Figure 68. Research Process Figure 69. Key Executives Interviewed

Scope & coverage.

Types
  • Continuous Use Pill
  • Combination Pill
  • Progestin-only Pill
Applications
  • Online Sales
  • Offline Sales
Companies covered
  • Allergan,plc (Actavis)
  • Mankind Pharma
  • Piramal Enterprises
  • Syzygy Healthcare
  • Bayer
  • Ferring B.V
  • Pfizer
  • Merck
  • Teva Pharmaceutical
  • Janssen Global Services

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Female Oral Contraceptives Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Female Oral Contraceptives Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Female Oral Contraceptives Market by Type
  6. 1.3.1 Continuous Use Pill
  7. 1.3.2 Combination Pill
  8. 1.3.3 Progestin-only Pill
  9. 1.4 Global Female Oral Contraceptives Market Size by Type
  10. 1.4.1 Global Female Oral Contraceptives Market Size Overview by Type (2021-2032)
  11. 1.4.2 Global Female Oral Contraceptives Historic Market Size Review by Type (2021-2026)
  12. 1.4.3 Global Female Oral Contraceptives Forecasted Market Size by Type (2027-2032)
  13. 1.5 Key Regions Market Size by Type
  14. 1.5.1 North America Female Oral Contraceptives Sales Breakdown by Type (2021-2026)
  15. 1.5.2 Europe Female Oral Contraceptives Sales Breakdown by Type (2021-2026)
  16. 1.5.3 Asia-Pacific Female Oral Contraceptives Sales Breakdown by Type (2021-2026)
  17. 1.5.4 South America Female Oral Contraceptives Sales Breakdown by Type (2021-2026)
  18. 1.5.5 Middle East and Africa Female Oral Contraceptives Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Female Oral Contraceptives Industry Trends
  2. 2.2 Female Oral Contraceptives Industry Drivers
  3. 2.3 Female Oral Contraceptives Industry Opportunities and Challenges
  4. 2.4 Female Oral Contraceptives Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Female Oral Contraceptives Revenue (2021-2026)
  2. 3.2 Global Top Players by Female Oral Contraceptives Sales (2021-2026)
  3. 3.3 Global Top Players by Female Oral Contraceptives Price (2021-2026)
  4. 3.4 Global Female Oral Contraceptives Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Female Oral Contraceptives Major Company Production Sites & Headquarters
  6. 3.6 Global Female Oral Contraceptives Company, Product Type & Application
  7. 3.7 Global Female Oral Contraceptives Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Female Oral Contraceptives Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Female Oral Contraceptives Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Female Oral Contraceptives Tier 1, Tier 2, and Tier 3
4 Female Oral Contraceptives Regional Status and Outlook
  1. 4.1 Global Female Oral Contraceptives Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Female Oral Contraceptives Historic Market Size by Region
  3. 4.2.1 Global Female Oral Contraceptives Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Female Oral Contraceptives Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Female Oral Contraceptives Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Female Oral Contraceptives Forecasted Market Size by Region
  7. 4.3.1 Global Female Oral Contraceptives Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Female Oral Contraceptives Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Female Oral Contraceptives Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Female Oral Contraceptives by Application
  1. 5.1 Female Oral Contraceptives Market by Application
  2. 5.1.1 Online Sales
  3. 5.1.2 Offline Sales
  4. 5.2 Global Female Oral Contraceptives Market Size by Application
  5. 5.2.1 Global Female Oral Contraceptives Market Size Overview by Application (2021-2032)
  6. 5.2.2 Global Female Oral Contraceptives Historic Market Size Review by Application (2021-2026)
  7. 5.2.3 Global Female Oral Contraceptives Forecasted Market Size by Application (2027-2032)
  8. 5.3 Key Regions Market Size by Application
  9. 5.3.1 North America Female Oral Contraceptives Sales Breakdown by Application (2021-2026)
  10. 5.3.2 Europe Female Oral Contraceptives Sales Breakdown by Application (2021-2026)
  11. 5.3.3 Asia-Pacific Female Oral Contraceptives Sales Breakdown by Application (2021-2026)
  12. 5.3.4 South America Female Oral Contraceptives Sales Breakdown by Application (2021-2026)
  13. 5.3.5 Middle East and Africa Female Oral Contraceptives Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Allergan,plc (Actavis)
  2. 6.1.1 Allergan,plc (Actavis) Company Information
  3. 6.1.2 Allergan,plc (Actavis) Business Overview
  4. 6.1.3 Allergan,plc (Actavis) Female Oral Contraceptives Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Allergan,plc (Actavis) Female Oral Contraceptives Product Portfolio
  6. 6.1.5 Allergan,plc (Actavis) Recent Developments
  7. 6.2 Mankind Pharma
  8. 6.2.1 Mankind Pharma Company Information
  9. 6.2.2 Mankind Pharma Business Overview
  10. 6.2.3 Mankind Pharma Female Oral Contraceptives Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Mankind Pharma Female Oral Contraceptives Product Portfolio
  12. 6.2.5 Mankind Pharma Recent Developments
  13. 6.3 Piramal Enterprises
  14. 6.3.1 Piramal Enterprises Company Information
  15. 6.3.2 Piramal Enterprises Business Overview
  16. 6.3.3 Piramal Enterprises Female Oral Contraceptives Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Piramal Enterprises Female Oral Contraceptives Product Portfolio
  18. 6.3.5 Piramal Enterprises Recent Developments
  19. 6.4 Syzygy Healthcare
  20. 6.4.1 Syzygy Healthcare Company Information
  21. 6.4.2 Syzygy Healthcare Business Overview
  22. 6.4.3 Syzygy Healthcare Female Oral Contraceptives Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Syzygy Healthcare Female Oral Contraceptives Product Portfolio
  24. 6.4.5 Syzygy Healthcare Recent Developments
  25. 6.5 Bayer
  26. 6.5.1 Bayer Company Information
  27. 6.5.2 Bayer Business Overview
  28. 6.5.3 Bayer Female Oral Contraceptives Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Bayer Female Oral Contraceptives Product Portfolio
  30. 6.5.5 Bayer Recent Developments
  31. 6.6 Ferring B.V
  32. 6.6.1 Ferring B.V Company Information
  33. 6.6.2 Ferring B.V Business Overview
  34. 6.6.3 Ferring B.V Female Oral Contraceptives Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Ferring B.V Female Oral Contraceptives Product Portfolio
  36. 6.6.5 Ferring B.V Recent Developments
  37. 6.7 Pfizer
  38. 6.7.1 Pfizer Company Information
  39. 6.7.2 Pfizer Business Overview
  40. 6.7.3 Pfizer Female Oral Contraceptives Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Pfizer Female Oral Contraceptives Product Portfolio
  42. 6.7.5 Pfizer Recent Developments
  43. 6.8 Merck
  44. 6.8.1 Merck Company Information
  45. 6.8.2 Merck Business Overview
  46. 6.8.3 Merck Female Oral Contraceptives Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Merck Female Oral Contraceptives Product Portfolio
  48. 6.8.5 Merck Recent Developments
  49. 6.9 Teva Pharmaceutical
  50. 6.9.1 Teva Pharmaceutical Company Information
  51. 6.9.2 Teva Pharmaceutical Business Overview
  52. 6.9.3 Teva Pharmaceutical Female Oral Contraceptives Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Teva Pharmaceutical Female Oral Contraceptives Product Portfolio
  54. 6.9.5 Teva Pharmaceutical Recent Developments
  55. 6.10 Janssen Global Services
  56. 6.10.1 Janssen Global Services Company Information
  57. 6.10.2 Janssen Global Services Business Overview
  58. 6.10.3 Janssen Global Services Female Oral Contraceptives Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Janssen Global Services Female Oral Contraceptives Product Portfolio
  60. 6.10.5 Janssen Global Services Recent Developments
7 North America by Country
  1. 7.1 North America Female Oral Contraceptives Sales by Country
  2. 7.1.1 North America Female Oral Contraceptives Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Female Oral Contraceptives Sales by Country (2021-2026)
  4. 7.1.3 North America Female Oral Contraceptives Sales Forecast by Country (2027-2032)
  5. 7.2 North America Female Oral Contraceptives Market Size by Country
  6. 7.2.1 North America Female Oral Contraceptives Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Female Oral Contraceptives Market Size by Country (2021-2026)
  8. 7.2.3 North America Female Oral Contraceptives Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Female Oral Contraceptives Sales by Country
  2. 8.1.1 Europe Female Oral Contraceptives Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Female Oral Contraceptives Sales by Country (2021-2026)
  4. 8.1.3 Europe Female Oral Contraceptives Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Female Oral Contraceptives Market Size by Country
  6. 8.2.1 Europe Female Oral Contraceptives Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Female Oral Contraceptives Market Size by Country (2021-2026)
  8. 8.2.3 Europe Female Oral Contraceptives Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Female Oral Contraceptives Sales by Country
  2. 9.1.1 Asia-Pacific Female Oral Contraceptives Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Female Oral Contraceptives Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Female Oral Contraceptives Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Female Oral Contraceptives Market Size by Country
  6. 9.2.1 Asia-Pacific Female Oral Contraceptives Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Female Oral Contraceptives Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Female Oral Contraceptives Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Female Oral Contraceptives Sales by Country
  2. 10.1.1 South America Female Oral Contraceptives Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Female Oral Contraceptives Sales by Country (2021-2026)
  4. 10.1.3 South America Female Oral Contraceptives Sales Forecast by Country (2027-2032)
  5. 10.2 South America Female Oral Contraceptives Market Size by Country
  6. 10.2.1 South America Female Oral Contraceptives Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Female Oral Contraceptives Market Size by Country (2021-2026)
  8. 10.2.3 South America Female Oral Contraceptives Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Female Oral Contraceptives Sales by Country
  2. 11.1.1 Middle East and Africa Female Oral Contraceptives Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Female Oral Contraceptives Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Female Oral Contraceptives Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Female Oral Contraceptives Market Size by Country
  6. 11.2.1 Middle East and Africa Female Oral Contraceptives Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Female Oral Contraceptives Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Female Oral Contraceptives Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Female Oral Contraceptives Value Chain Analysis
  2. 12.1.1 Female Oral Contraceptives Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Female Oral Contraceptives Production Mode & Process
  7. 12.2 Female Oral Contraceptives Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Female Oral Contraceptives Distributors
  10. 12.2.3 Female Oral Contraceptives Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst